The high mortality rate associated with coronary heart disease (CHD) has driven intensive research in cardiac image analysis. The advent of computed tomography angiography (CTA) has turned non-invasive diagnosis of cardiovascular anomalies into reality as calcified coronary plaques can be easily identified due to high intensity values. However, detection and quantification of the non-calcified plaques in CTA is still a challenging problem because of their lower intensity values, which are often similar to the nearby blood and muscle tissues. In this work, we propose Bayesian posterior based model for precise quantification of the non-calcified plaques in CTA imagery. The only indicator of non-calcified plaques in CTA is relatively lower intensity. Hence, we exploited intensity variations to discriminate voxels into lumen and plaque classes. Based on the normal coronary segments, we computed the vessel-wall thickness in first step. In the subsequent step, we removed vessel wall from the segmented tree and employed Gaussian Mixture Model to compute optimal distribution parameters. In the final step, distribution parameters were employed in Bayesian posterior model to classify voxels into lumen or plaque. A total of 18 CTA volumes were analyzed in this work using two different approaches. According to the experimental results, mean Jaccard overlap is around 88% with respect to the manual expert. In terms of sensitivity, specificity and accuracy, the proposed method achieves 84.13% ,79.15% and 82.02% success, respectively. Conclusion: According to the experimental results, it is shown that the proposed plaque quantification method achieves accuracy equivalent to human experts.
The consistent performance for multi-vendor, multi-institution data demonstrates the reproducibility of our method across different CTA datasets with a good agreement with manual expert annotations.
This is the accepted version of the paper.This version of the publication may differ from the final published version.
Permanent repository link
AbstractBackground and Objective: State-of-the-art medical imaging techniques have enabled non-invasive imaging of the internal organs. However, high volumes of imaging data make manual interpretation and delineation of abnormalities cumbersome for clinicians. These challenges have driven intensive research into efficient medical image segmentation. In this work, we propose a hybrid regionbased energy formulation for effective segmentation in computed tomography angiography (CTA) imagery.Methods: The proposed hybrid energy couples an intensity-based local term with an efficient discontinuity-based global model of the image for optimal segmentation. The segmentation is achieved using a level set formulation due to the computational robustness. After validating the statistical significance of the hybrid energy, we applied the proposed model to solve an important clinical problem of 3D coronary segmentation. An improved seed detection method is used to initialize the level set evolution. Moreover, we employed an auto-correction feature that captures the emerging peripheries during the curve evolution for completeness of the coronary tree. sults demonstrate the effectiveness of the proposed framework with a consistent mean sensitivity and specificity measures of 80% across the CTA data. Moreover, a high degree of agreement with respect to the inter-observer differences justifies the generalization of the proposed method.Conclusions: The proposed method is effective to segment the coronary tree from the CTA volume based on hybrid image based energy, which can improve the clinicians ability to detect arterial abnormalities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.